Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients

OBJECTIVES: Demonstrate the safety and effectiveness of highly purified CD133+ autologous stem cells in critical limb ischemia (CLI). DESIGN: Prospective single-center not randomized. Clinicaltrials.gov identifier: NCT01595776 METHODS: Eight patients with a history of stable CLI were enrolled in a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Arici, Vittorio, Perotti, Cesare, Fabrizio, Calliada, Del Fante, Claudia, Ragni, Franco, Alessandrino, Francesco, Viarengo, Gianluca, Pagani, Michele, Moia, Alessia, Tinelli, Carmine, Bozzani, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630831/
https://www.ncbi.nlm.nih.gov/pubmed/26526721
http://dx.doi.org/10.1186/s12967-015-0697-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630831/
https://www.ncbi.nlm.nih.gov/pubmed/26526721
http://dx.doi.org/10.1186/s12967-015-0697-4

Ejemplares similares